These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24170168)

  • 1. Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):800-4. PubMed ID: 24170168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous treatment of symptomatic non-parasitic hepatic cysts. Initial experience with single-session sclerotherapy with polidocanol.
    Spârchez Z; Radu P; Zaharie F; Al Hajjar N; Sparchez M
    Med Ultrason; 2014 Sep; 16(3):222-8. PubMed ID: 25110763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous sclerotherapy using a 4 F pigtail catheter and 40 milliliters of 5% ethanolamine oleate for symptomatic large hepatic cysts.
    Miyayama S; Yamashiro M; Ikeda R; Matsumoto J; Ogawa N; Notsumata K
    Diagn Interv Radiol; 2022 Mar; 28(2):149-155. PubMed ID: 35548899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous aspiration and ethanolamine oleate sclerotherapy for sustained resolution of symptomatic polycystic liver disease: an initial experience.
    Nakaoka R; Das K; Kudo M; Chung H; Innoue T
    AJR Am J Roentgenol; 2009 Dec; 193(6):1540-5. PubMed ID: 19933645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of percutaneous ethanol and polidocanol sclerotherapy in the management of simple renal cysts.
    Yonguc T; Sen V; Aydogdu O; Bozkurt IH; Yarimoglu S; Polat S
    Int Urol Nephrol; 2015 Apr; 47(4):603-7. PubMed ID: 25778818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease.
    Takita M; Iwanishi M; Minami T; Kono M; Chishina H; Arizumi T; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Naoshi N; Kudo M
    Dig Dis; 2016; 34(6):654-658. PubMed ID: 27750233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-guided polidocanol foam sclerotherapy for symptomatic giant hepatic cyst: A single-center experience.
    Eso Y; Shimizu H; Takai A; Takahashi K; Seno H
    Hepatol Res; 2022 Jun; 52(6):557-565. PubMed ID: 35355375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience.
    Yamamoto K; Sakaguchi H; Anai H; Tanaka T; Morimoto K; Kichikawa K; Uchida H
    Cardiovasc Intervent Radiol; 2005; 28(6):751-5. PubMed ID: 16132390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.
    Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S
    Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy.
    Jang SY; Park SY; Tak WY; Kweon YO; Ryeom H
    Acta Radiol; 2016 Oct; 57(10):1205-9. PubMed ID: 26787678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.
    Wijnands TF; Ronot M; Gevers TJ; Benzimra J; Kool LJ; Vilgrain V; Drenth JP
    Eur Radiol; 2017 Feb; 27(2):741-748. PubMed ID: 27180184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A therapeutic alternative in the treatment of epididymal cysts: percutaneous sclerotherapy.
    Pieri S; Agresti P; Morucci M; Carnabuci A; De Medici L
    Radiol Med; 2003; 105(5-6):462-70. PubMed ID: 12949457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon-occluded retrograde transvenous obliteration of gastric varices: use of CT-guided foam sclerotherapy to optimize technique.
    Koizumi J; Hashimoto T; Myojin K; Itou C; Kagawa T; Nishibe T; Janne d'Othée B
    AJR Am J Roentgenol; 2012 Jul; 199(1):200-7. PubMed ID: 22733913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle sclerotherapy as a new effective therapeutic approach for nonparasitic splenic cysts: a case series.
    Rifai K; Berger D; Potthoff A; Manns MP; Gebel MJ
    Dig Liver Dis; 2013 Jul; 45(7):595-9. PubMed ID: 23339772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of polidocanol and tetracycline in the sclerotherapy of testicular hydrocele and epididymal cyst.
    Daehlin L; Tønder B; Kapstad L
    Br J Urol; 1997 Sep; 80(3):468-71. PubMed ID: 9313670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients.
    Chung SH; Lee MS; Kim KS; Kim SI; Won JY; Lee DY; Lee KH
    Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1236-43. PubMed ID: 21290126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous treatment of congenital splenic cysts: drainage and sclerotherapy with polidocanol.
    Goktay AY; Secil M; Ozcan MA; Dicle O
    Cardiovasc Intervent Radiol; 2006; 29(3):469-72. PubMed ID: 16184333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.